Shopping Cart
- Remove All
- Your shopping cart is currently empty
HMGB1-IN-1 (compound 6) exhibits potent inhibition of NO production in RAW264.7 cells, with an IC50 of 15.9 ± 0.6 μM, and effectively disrupts the HMGB1/NF-κB/NLRP3 signaling pathway, demonstrating promising anti-inflammatory and anti-sepsis properties, particularly in the context of renal injury [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | HMGB1-IN-1 (compound 6) exhibits potent inhibition of NO production in RAW264.7 cells, with an IC50 of 15.9 ± 0.6 μM, and effectively disrupts the HMGB1/NF-κB/NLRP3 signaling pathway, demonstrating promising anti-inflammatory and anti-sepsis properties, particularly in the context of renal injury [1]. |
In vitro | HMGB1-IN-1 (compound 6) (0-30 μM, 0-48 h) reduces IL-1β and TNF-α levels in RAW264.7 and HK-2 cells and demonstrates dose-dependent downregulation of NLRP3, P-NF-κB p65, and HMGB1 in activated HK-2 cells [1]. |
In vivo | HMGB1-IN-1 (compound 6), when administered intraperitoneally at doses ranging from 15 to 30 mg/kg, demonstrates potent anti-inflammatory activity [1]. |
Molecular Weight | 1042.22 |
Formula | C57H75N3O15 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.